Imran Talatinsider trades

In SEC Form 4 filings, Imran Talat is listed as Chief Executive Officer of Rani Therapeutics Holdings, Inc. (RANI). Imran Talat reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 29.

Companies and roles

Company	Role	Transactions	Last filed
RANIRani Therapeutics Holdings, Inc.	Chief Executive Officer	1	Sep 29

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-29

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RANIRani Therapeutics Holdings, Inc.	Sep 27	Sep 29	F	7,928	$0.76	$6,019	461,808	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.